Sales of drugs maker Slovakofarma increased 21.8 per cent from 2000 to Sk7.74 billion last year, while net profits fell from Sk350 million to Sk221 million in the same period. The firm blamed the profit fall on increased spending on marketing and product development.
Compiled by Tom Nicholson from press reports.
The Slovak Spectator cannot vouch for the accuracy of the information presented in its Flash News postings.
16. Apr 2002 at 10:52